Search Results - Paul Hourd
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
A 3D-bioprinting exemplar of the consequences of the regulatory requirements on customised processes by Paul Hourd, Nick Medcalf, David Williams, Joel Segal
Published 2015
Default Article -
5
Human cell culture process capability: a comparison of manual and automated production by Yang Liu, Paul Hourd, Amit Chandra, David Williams
Published 2010
Default Article -
6
Regenerative medicine, resource and regulation: lessons learned from the remedi project by Patrick J. Ginty, Erin Rayment, Paul Hourd, David Williams
Published 2011
Default Article -
7
-
8
-
9
Manufacture of a human mesenchymal stem cell population using an automated cell culture platform by Rob Thomas, Amit Chandra, Yang Liu, Paul Hourd, Paul Conway, David Williams
Published 2007
Default Article -
10
-
11
Precision manufacturing for clinical-quality regenerative medicines by David Williams, Rob Thomas, Paul Hourd, Amit Chandra, Elizabeth Ratcliffe, Yang Liu, Erin Rayment, J. Richard Archer
Published 2012
Default Article -
12
-
13
Improving umbilical cord blood processing to increase total nucleated cell count yield and reduce cord input wastage by managing the consequences of input variation by May W. Naing, Daniel A. Gibson, Paul Hourd, Susana G. Gomez, Roger B.V. Horton, Joel Segal, David Williams
Published 2015
Default Article